Abstract
Over the years, physicians have been searching for an effective way to treat Peyronie’s disease (PD). This disorder remains poorly understood. As a result, there is no straightforward reliable therapy. When it is felt that medical therapy is in order, it is best started at the early stages of acute inflammation, when the therapy can potentially prevent the evolution of fibrosis. A variety of combined treatments have been tried in the past appearing to give better results than monotherapy. Various types of energy transfer, including shockwave therapy, orthovoltage radiation, ultrasound, laser therapy, and shortwave diathermy, have been used for PD. The best reported clinical results have been obtained by combining laser therapy with shockwave therapy, especially for pain resolution. Treatment outcomes concerning reducing penile curvature and plaque resorption have been disappointing. Published reports have demonstrated the best results of combination therapy with shockwave therapy and intralesional injection of verapamil as this approach appears not only to reduce pain but also to improve penile deformity. This chapter reviews the results of nonsurgical combination therapy in the treatment ofPD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hauck W, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W. Extracorporeal shock wavetherapy for Peyronie’ s disease: exploratory meta-analysis of clinical trials. J Urol 2004; 171: 740–745.
Mirone C, Imbimbo A, Palmieri F. Fusco: our experience on the association of a new physical andmedical therapy in patients suffering from induratio penis plastica. Eur Urol 1999; 36: 327–330.
Levine LA. Review of current nonsurgical management of Peyronie’ s disease. Int J Impot Res 2003; 15(suppl 5): S113–S120.
Kerrshenobich D, Vargas F, Garcia-Tsao G, Perez Tamayo R, Gent M, Rojkind M. Colchicine in thetreatment of cirrhosis of the liver. N Engl J Med 1988; 318: 1709–1713.
Harris D Jr, Krame SM. Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthritis Rheum 1971; 14: 669–684.
Akkus J, Breza S, Carrier A, Kadioglu J, Rehman T, Lue F. Is colchicine effective on Peyronie’s disease? A pilot study. Urology 1994; 44: 291–295.
Riedl R, Plas E, Engelhardt P, Daha K, Pflueger H. Iontophoresis for treatment of Peyronie’s disease. J Urol 2000; 163:95–99.
Rodrigues I, Hian Njo K, Karim AB. Results of radiotherapy and vitamin E in the treatment of Peyronie’s disease. Int J Radiat Oncl Biol Phys 1995; 31(3): 571–576.
Hauck W, Attinkilic BM, Ludwig M, et al. Extracorporeal shock wave therapy in the treatment ofPeyronie’s disease. First results of a case controlled approach. Eur Urol 2000; 38(6): 663–670.
Digelmann RF. Cellular and biochemical aspects of normal and abnormal wound healing: an overview. J Urol 1997; 157:298–302.
Devine CJ Jr, Somers KD, Jordan GH, Schlossberg SM. Proposal: trauma as the cause of the Peyronie’slesion. J Urol 1997; 157: 285–290.
Mirone C, Imbimbo A, Palmieri N, Longo F, Fusco G. Taj ana: a new biopsy technique to investigatePeyronie’s disease associated histologic alterations: results with two different forms of therapy. EurUrol 2002; 42: 239–244.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Mirone, V. (2007). Combination Nonsurgical Therapy. In: Levine, L.A. (eds) Peyronie’S Disease. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59745-161-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-59745-161-1_10
Publisher Name: Humana Press
Print ISBN: 978-1-58829-614-6
Online ISBN: 978-1-59745-161-1
eBook Packages: MedicineMedicine (R0)